Menadione sodium bisulfite cas no:130-37-0
Synonyms: 1,2,3,4-Tetrahydro-2-methyl-1,4-dioxo-2-naphthalenesulfonic acid sodium salt;2,3-Dihydro-2-methyl-1,4-naphthoquinone-2-sulfonate sodium;Golagen K;Hykinone;Ido-K;Kavitamin;Kawitan;Klotogen F;Klotogen F 227;MSBC;Vikasol;Vitamin K injection;2-Naphthalenesulfonicacid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt (1:1);Bisulfite sodique de menadione [INN-French];CCRIS 7112;EINECS 204-987-0;UNII-6XF3C2HK77;Vikasolum;
NameMenadione sodium bisulfite
CAS130-37-0
Synonyms1,2,3,4-Tetrahydro-2-methyl-1,4-dioxo-2-naphthalenesulfonic acid sodium salt;2,3-Dihydro-2-methyl-1,4-naphthoquinone-2-sulfonate sodium;Golagen K;Hykinone;Ido-K;Kavitamin;Kawitan;Klotogen F;Klotogen F 227;MSBC;Vikasol;Vitamin K injection;2-Naphthalenesulfonicacid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt (1:1);Bisulfite sodique de menadione [INN-French];CCRIS 7112;EINECS 204-987-0;UNII-6XF3C2HK77;Vikasolum;
EINECS(EC#)204-987-0
Molecular FormulaC11H9NaO5S
Molecular Weight276.24093
AppearanceCrystalline powder
storage temp−20°C
Hazard Xi: Irritant;
Risk R36
Safety
Human mutation data reported. When heated to decomposition it emits toxic vapors of SOx.
Hazard Codes: 
Xi
Risk Statements: 36
Safety Statements: 26
WGK Germany: 3
| 1. |
|
dni-hmn:leu 25 µmol/L
|
|
BCPCA6 Biochemical Pharmacology. 41 (1991),1283. |
| 2. |
|
dni-hmn:oth 50 µmol/L
|
|
BCPCA6 Biochemical Pharmacology. 41 (1991),1283. BCPCA6 Biochemical Pharmacology. 41 (1991),1283. |
| 3. |
|
oth-hmn:leu 50 µmol/L
|
|
BCPCA6 Biochemical Pharmacology. 41 (1991),1283. |
| 4. |
|
oth-hmn:oth 25 µmol/L
|
|
BCPCA6 Biochemical Pharmacology. 41 (1991),1283. |
